Stéphane Chevaliez

5.4k total citations
144 papers, 3.6k citations indexed

About

Stéphane Chevaliez is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Stéphane Chevaliez has authored 144 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Hepatology, 120 papers in Epidemiology and 34 papers in Infectious Diseases. Recurrent topics in Stéphane Chevaliez's work include Hepatitis C virus research (124 papers), Hepatitis B Virus Studies (103 papers) and Liver Disease Diagnosis and Treatment (68 papers). Stéphane Chevaliez is often cited by papers focused on Hepatitis C virus research (124 papers), Hepatitis B Virus Studies (103 papers) and Liver Disease Diagnosis and Treatment (68 papers). Stéphane Chevaliez collaborates with scholars based in France, United States and United Kingdom. Stéphane Chevaliez's co-authors include Jean–Michel Pawlotsky, Christophe Hézode, Magali Bouvier‐Alias, John G. McHutchison, Alexandre Soulier, Rozenn Brillet, Christophe Rodriguez, Lila Poiteau, Syria Laperche and Stéphane Bahrami and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Stéphane Chevaliez

135 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stéphane Chevaliez France	35	2.9k	2.9k	831	277	205	144	3.6k
Phillip S. Pang United States	27	2.2k 0.8×	2.0k 0.7×	679 0.8×	284 1.0×	88 0.4×	55	2.8k
Jacqueline C. Melpolder United States	9	2.9k 1.0×	2.6k 0.9×	380 0.5×	187 0.7×	148 0.7×	11	3.4k
Teresa I. Ng United States	26	1.1k 0.4×	1.4k 0.5×	661 0.8×	230 0.8×	158 0.8×	59	2.0k
Thomas Vanwolleghem Belgium	23	1.7k 0.6×	1.9k 0.7×	407 0.5×	229 0.8×	392 1.9×	84	2.5k
Janice A. Kolberg United States	26	2.9k 1.0×	2.8k 1.0×	840 1.0×	644 2.3×	180 0.9×	63	4.3k
M. S. Urdea United States	15	3.2k 1.1×	2.8k 1.0×	529 0.6×	358 1.3×	89 0.4×	18	3.7k
Daryl Lau United States	35	3.6k 1.3×	3.8k 1.3×	612 0.7×	682 2.5×	1.0k 5.0×	108	5.1k
Jason T. Blackard United States	31	1.9k 0.7×	1.8k 0.6×	823 1.0×	239 0.9×	431 2.1×	151	3.1k
G Verme Italy	37	4.2k 1.5×	4.5k 1.6×	575 0.7×	335 1.2×	216 1.1×	136	5.6k
A. Thompson Australia	24	1.6k 0.6×	1.7k 0.6×	344 0.4×	171 0.6×	379 1.8×	75	2.2k

Countries citing papers authored by Stéphane Chevaliez

Since Specialization

Citations

This map shows the geographic impact of Stéphane Chevaliez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Chevaliez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Chevaliez more than expected).

Fields of papers citing papers by Stéphane Chevaliez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Chevaliez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Chevaliez. The network helps show where Stéphane Chevaliez may publish in the future.

Co-authorship network of co-authors of Stéphane Chevaliez

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Chevaliez. A scholar is included among the top collaborators of Stéphane Chevaliez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Chevaliez. Stéphane Chevaliez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ingiliz, Patrick, et al.. (2025). Performance of the cobas 5800 System for Hepatitis B virus DNA and Hepatitis C virus RNA quantification. Diagnostic Microbiology and Infectious Disease. 112(2). 116753–116753.

Mouna, Lina, Sepideh Akhavan, Stéphane Chevaliez, et al.. (2021). Accuracy assessment of total or IgG Immunoglobulin to hepatitis A virus tests around immunity threshold.. Journal of Clinical Virology. 146. 105059–105059. 4 indexed citations

Chevaliez, Stéphane, Françoise Roudot‐Thoraval, Christophe Hézode, Jean–Michel Pawlotsky, & Richard Njouom. (2021). Performance of rapid diagnostic tests for hepatitis B surface antigen detection in serum or plasma. Diagnostic Microbiology and Infectious Disease. 100(2). 115353–115353. 9 indexed citations

Chevaliez, Stéphane, Thomas Müller, Luna Colagrossi, et al.. (2021). Multicenter Evaluation of the Cepheid Xpert® HBV Viral Load Test. Diagnostics. 11(2). 297–297. 16 indexed citations

Jauffret‐Roustide, Marie, Francis Barin, S. Brunet, et al.. (2020). Migration experiences, life conditions, and drug use practices of Russian-speaking drug users who live in Paris: a mixed-method analysis from the ANRS-Coquelicot study. Harm Reduction Journal. 17(1). 55–55. 7 indexed citations

Fourati, Slim, Christophe Rodriguez, Alexandre Soulier, et al.. (2020). Fitness‐associated substitutions following failure of direct‐acting antivirals assessed by deep sequencing of full‐length hepatitis C virus genomes. Alimentary Pharmacology & Therapeutics. 52(10). 1583–1591. 5 indexed citations

Lédinghen, Victor de, Clovis Lusivika‐Nzinga, Jean–Pierre Bronowicki, et al.. (2020). Sofosbuvir‐Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real‐life experience from the HEPATHER ANRS CO22 cohort. Journal of Viral Hepatitis. 27(10). 964–973. 4 indexed citations

Lydié, Nathalie, Leïla Saboni, Arnaud Gautier, et al.. (2018). Innovative Approach for Enhancing Testing of HIV, Hepatitis B, and Hepatitis C in the General Population: Protocol for an Acceptability and Feasibility Study (BaroTest 2016). JMIR Research Protocols. 7(10). e180–e180. 6 indexed citations

Fourati, Slim, Dominique Challine, Jean‐Dominique Poveda, et al.. (2017). Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay. Journal of Clinical Virology. 92. 69–74. 7 indexed citations

10.

Chevaliez, Stéphane, Lila Poiteau, Isabelle Rosa, et al.. (2016). Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care. Clinical Microbiology and Infection. 22(5). 459.e1–459.e6. 47 indexed citations

11.

Cloherty, Gavin, Daniel E. Cohen, Christoph Sarrazin, et al.. (2014). HCV RNA Assay Sensitivity Impacts the Management of Patients Treated with Direct-Acting Antivirals. Antiviral Therapy. 20(2). 177–183. 15 indexed citations

12.

Cotte, Laurent, Aurélie Barrail‐Tran, Corine Vincent, et al.. (2014). Telaprevir Enhances Ribavirin-Induced Anaemia through Renal Function Impairment. Antiviral Therapy. 20(5). 479–486. 4 indexed citations

13.

Jilg, Nikolaus, Wenyu Lin, Jian Hong, et al.. (2013). Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus. Hepatology. 59(4). 1250–1261. 89 indexed citations

14.

Chevaliez, Stéphane & Tarik Asselah. (2011). Mechanisms of non-response to antiviral treatment in chronic hepatitis C. Clinics and Research in Hepatology and Gastroenterology. 35. S31–S41. 19 indexed citations

15.

Chevaliez, Stéphane, Christophe Hézode, Alexandre Soulier, et al.. (2011). High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial). Gastroenterology. 141(1). 119–127. 23 indexed citations

16.

Cacoub, P., Philippe Halfon, Éric Rosenthal, et al.. (2010). Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: Modifications in three consecutive large surveys between 2004 and 2009. Journal of Hepatology. 53(2). 230–237. 9 indexed citations

17.

Chevaliez, Stéphane & Jean–Michel Pawlotsky. (2009). How to use virological tools for optimal management of chronic hepatitis C. Liver International. 29(s1). 9–14. 34 indexed citations

18.

Morice, Yoann, Maxime Ratinier, Stéphane Chevaliez, et al.. (2009). Seroconversion to hepatitis C virus alternate reading frame protein during acute infection #. Hepatology. 49(5). 1449–1459. 12 indexed citations

19.

Chevaliez, Stéphane & Jean–Michel Pawlotsky. (2008). Interferons and Their Use in Persistent Viral Infections. Handbook of experimental pharmacology. 203–241. 19 indexed citations

20.

Chevaliez, Stéphane, Rozenn Brillet, C. Hézode, Daniel Dhumeaux, & Jean–Michel Pawlotsky. (2006). P.228 Assessment of ribavirin mutagenic properties in vivo and the influence of interferon alpha-induced reduction of hepatitis C virus RNA load upon therapy. Journal of Clinical Virology. 36. S132–S132. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact